Research
Research
June 29, 2026 • 3 Min
ASCO 2026: An Update on Research
Daraxonrasib wasn’t the only research news to come out at ASCO 2026. Learn about other new drugs and tests for pancreatic cancer.
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
May 18, 2026 • 3 Min
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
Research
April 30, 2026 • 5 Min
2026 AACR Annual Meeting Gives Hope for the Future
Research highlights from the 2026 AACR Meeting featured advances in pancreatic cancer treatment, focusing on KRAS and vaccines,
Survivor Stories
Survivor Stories
November 2, 2022 • 3 Min
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Survivor Stories
June 27, 2022 • 4 Min
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Survivor Stories
June 1, 2022 • 5 Min
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
